{"id":"sertraline-pill","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Insomnia"}]},"_chembl":{"chemblId":"CHEMBL809","moleculeType":"Small molecule","molecularWeight":"306.24"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the reabsorption of serotonin, sertraline allows more serotonin to be available in the brain, which can help improve mood and reduce symptoms of depression and anxiety.","oneSentence":"Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases the levels of serotonin in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:06.351Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Obsessive-compulsive disorder"},{"name":"Panic disorder"},{"name":"Post-traumatic stress disorder"},{"name":"Premenstrual dysphoric disorder"}]},"trialDetails":[{"nctId":"NCT04183205","phase":"PHASE4","title":"Predicting SSRI Efficacy in Veterans With PTSD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-09-11","conditions":"Posttraumatic Stress Disorder, Major Depressive Disorder","enrollment":26},{"nctId":"NCT06384209","phase":"NA","title":"The Friendship Bench Plus Trial","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-06-26","conditions":"Major Depressive Disorder, Severe Depressive Episode Without Psychotic Symptoms","enrollment":296},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT06698666","phase":"PHASE3","title":"Efficacy of Statins Among Major Depressive Disorder","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Major Depressive Disorder, MDD","enrollment":145},{"nctId":"NCT04124614","phase":"PHASE3","title":"Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2019-10-17","conditions":"Post Traumatic Stress Disorder","enrollment":450},{"nctId":"NCT06704594","phase":"PHASE4","title":"Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-05-14","conditions":"Premenstrual Dysphoric Disorder (PMDD)","enrollment":288},{"nctId":"NCT04174170","phase":"PHASE3","title":"Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2019-10-30","conditions":"Post Traumatic Stress Disorder","enrollment":591},{"nctId":"NCT06778824","phase":"NA","title":"Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.","status":"RECRUITING","sponsor":"Hualien Tzu Chi General Hospital","startDate":"2024-04-02","conditions":"Gut-Brain Disorders, GERD Without Erosive Esophagitis","enrollment":610},{"nctId":"NCT02890212","phase":"NA","title":"Selenium as Augmentation Treatment for Sertraline Resistant Major Depression","status":"SUSPENDED","sponsor":"University of Sao Paulo General Hospital","startDate":"2005-08","conditions":"Major Depression","enrollment":60},{"nctId":"NCT03279471","phase":"PHASE2","title":"Specifying and Treating Anxiety in Autism Research","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2017-10-01","conditions":"Autism Spectrum Disorder, Anxiety","enrollment":68},{"nctId":"NCT05544071","phase":"NA","title":"the Safety and Effectiveness of Precise rTMS Based on Neuroimaging in the Treatment of Adolescent Depression With Anhedoniadepression With Anhedonia","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2023-02-12","conditions":"Major Depressive Disorder, Repetitive Transcranial Magnetic Stimulation","enrollment":88},{"nctId":"NCT05950061","phase":"PHASE3","title":"Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder","status":"COMPLETED","sponsor":"KRL Hospital, Islamabad","startDate":"2022-06-01","conditions":"Major Depressive Disorder","enrollment":744},{"nctId":"NCT03294525","phase":"","title":"Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders","status":"UNKNOWN","sponsor":"Peking University","startDate":"2016-01","conditions":"Affective Disorder","enrollment":400},{"nctId":"NCT02137369","phase":"PHASE4","title":"The ISLAND Study: InSuLa Assessed Needs for Depression","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-09","conditions":"Depression","enrollment":77},{"nctId":"NCT00262223","phase":"PHASE2","title":"Combined Treatment for Alcohol-Dependent Individuals With PTSD","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-05","conditions":"Stress Disorders, Post-Traumatic, Alcohol Abuse, Substance-Related Disorders","enrollment":69},{"nctId":"NCT04171193","phase":"PHASE2","title":"Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2019-12","conditions":"Depressive Disorder, Major, Treatment Resistant Depression, Depressive Episode","enrollment":30},{"nctId":"NCT00744328","phase":"PHASE4","title":"Postpartum Depression: Transdermal Estradiol Versus Sertraline","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-08","conditions":"Postpartum Depression","enrollment":85},{"nctId":"NCT01407094","phase":"PHASE2","title":"Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2011-07-29","conditions":"Depression","enrollment":296},{"nctId":"NCT01098318","phase":"PHASE3","title":"Rhodiola Rosea Therapy of Major Depressive Disorder","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-06","conditions":"Depression","enrollment":58},{"nctId":"NCT00052078","phase":"PHASE3","title":"Child and Adolescent Anxiety Disorders (CAMS)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2003-01","conditions":"Anxiety Disorders, Social Phobia, Generalized Anxiety Disorder","enrollment":488},{"nctId":"NCT00043550","phase":"PHASE3","title":"Treatments for Depression: Drug Versus Psychotherapy","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2001-11","conditions":"Depression","enrollment":156},{"nctId":"NCT00536198","phase":"PHASE4","title":"Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-11-06","conditions":"Premenstrual Dysphoric Disorder","enrollment":252},{"nctId":"NCT00078767","phase":"PHASE3","title":"Pharmacologic Treatment of PTSD in Sexually Abused Children","status":"COMPLETED","sponsor":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","startDate":"2001-04","conditions":"Stress Disorders, Post-Traumatic","enrollment":24},{"nctId":"NCT01385709","phase":"","title":"The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2008-08","conditions":"Bipolar Affective Disorders, Cyclothymic Disorder, Schizoaffective Disorder","enrollment":29},{"nctId":"NCT00602355","phase":"PHASE2","title":"Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression","status":"COMPLETED","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2008-02","conditions":"Depression, Postpartum","enrollment":162},{"nctId":"NCT01178671","phase":"PHASE4","title":"Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial","status":"COMPLETED","sponsor":"Research Foundation for Mental Hygiene, Inc.","startDate":"2010-07","conditions":"Posttraumatic Stress Disorder","enrollment":38},{"nctId":"NCT00302068","phase":"PHASE3","title":"Exercise to Treat Depression in Individuals With Coronary Heart Disease","status":"COMPLETED","sponsor":"Duke University","startDate":"2006-07","conditions":"Depression, Heart Diseases","enrollment":101},{"nctId":"NCT00118417","phase":"PHASE2, PHASE3","title":"Therapies for Treatment-Resistant Panic Disorder Symptoms","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"1999-03","conditions":"Panic Disorder","enrollment":46},{"nctId":"NCT00331305","phase":"PHASE3","title":"Exercise Training Versus Drug Therapy for Treating Depression in Older Adults","status":"COMPLETED","sponsor":"Duke University","startDate":"1999-08","conditions":"Depression","enrollment":457},{"nctId":"NCT00299611","phase":"PHASE2, PHASE3","title":"Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder","status":"TERMINATED","sponsor":"Duke University","startDate":"2005-11","conditions":"Obsessive-Compulsive Disorder","enrollment":12},{"nctId":"NCT00078286","phase":"PHASE2, PHASE3","title":"Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure","status":"COMPLETED","sponsor":"Duke University","startDate":"2003-11","conditions":"Heart Failure, Congestive, Chronic Heart Failure, Depression","enrollment":469},{"nctId":"NCT00944996","phase":"NA","title":"Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression","status":"COMPLETED","sponsor":"Tirat Carmel Mental Health Center","startDate":"2009-06","conditions":"Major Depression","enrollment":100},{"nctId":"NCT00208117","phase":"PHASE1","title":"A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2005-04","conditions":"Depression, Coronary Artery Disease (CAD), Acute Coronary Syndrome (ACS)","enrollment":7},{"nctId":"NCT01033084","phase":"PHASE2, PHASE3","title":"Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-12","conditions":"Depressive Disorder, Major","enrollment":120},{"nctId":"NCT01114100","phase":"PHASE4","title":"The Effects of Treatment With Sertraline for Noncardiac Chest Pain","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2000-01","conditions":"Panic Attacks, Chest Pain, Depression","enrollment":210}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BREAST CANCER"},{"count":1,"reaction":"CATAPLEXY"},{"count":1,"reaction":"CONTUSION"},{"count":1,"reaction":"FALL"},{"count":1,"reaction":"HAEMORRHOIDS"},{"count":1,"reaction":"PAIN"},{"count":1,"reaction":"RENAL INJURY"},{"count":1,"reaction":"RIB FRACTURE"}],"_approvalHistory":[],"publicationCount":64,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Antidepressants-Sertraline","Zoloft"],"phase":"phase_3","status":"active","brandName":"Sertraline Pill","genericName":"Sertraline Pill","companyName":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","companyId":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-resea","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sertraline is a small molecule medication used to treat various conditions, including depression, posttraumatic stress disorder, obsessive-compulsive disorder, and others, as indicated by ClinicalTrials.gov. It is available in pill form and is used in clinical trials to compare its effectiveness against a placebo.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}